A detailed history of Ronald Blue Trust, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 59 shares of PCRX stock, worth $965. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 33 78.79%
Holding current value
$965
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$11.7 - $28.46 $304 - $739
26 Added 78.79%
59 $0
Q2 2024

Jul 18, 2024

BUY
$25.5 - $31.51 $841 - $1,039
33 New
33 $0
Q4 2023

Jan 18, 2024

BUY
$26.32 - $34.31 $210 - $274
8 New
8 $0
Q2 2023

Jul 14, 2023

BUY
$36.12 - $47.5 $433 - $570
12 New
12 $0

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $750M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.